AKAP12 and prostate cancer: AKAP12 (also known as SSeCKS, Gravin, or AKAP250) functions as a metastasis suppressor in prostate cancer models [7–9] based on its ability to scaffold kinases such as Src, PKC, and PKA, and to suppress their activation of downstream signaling mediators [10].